dr. Fatih Anfasa, Sp.PD, M.Sc., Ph.D

• Spesialis Penyakit Dalam

• 2006: Bachelor of Medicine, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
• 2008: Medical Doctor, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
• 2012: Master of Infection and Immunity, Erasmus University Medical Center, Rotterdam, The Netherlands
• 2020: Doctor of philosophy, Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands
• 2024: Internal medicine specialist, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia

Honours & Awards

• 2008: Best oral presentation (2nd position), Annual Meeting of Internal Medicine (PIT IPD) 2008, Jakarta, Indonesia
• 2008: Cum laude graduate award for medical doctor education from the Rector of Universitas Indonesia 
• 2008: Cum laude graduate award for medical doctor education from Faculty of Medicine, Universitas Indonesia 
• 2010: Full scholarship for research master program in infection and immunity, Postgraduate School of Molecular Medicine, Eramus University Medical Center
• 2012: Excellent research master student award from Royal Netherlands Academy of Arts and Sciences (KNAW) 
• 2013: PhD Scholarship from the Indonesian Directorate General of Higher  Education (DIKTI), Ministry of Education and Culture, Republic of Indonesia
• 2020: Infection and Immunity (I&I) fund from Research Master Infection and Immunity Program, Postgraduate School of Molecular Medicine, Erasmus University Medical Center
• 2024: Cum laude graduate award for internal medicine residency program from Rector of Universitas Indonesia

Courses and Conferences

• 2014: Article 9 - certification to design animal experiment project in the Netherlands
• 2016: Course in Virology, Erasmus University Medical Center, Rotterdam, the Netherlands
• 2016: Dutch Annual Virology Symposium, Groningen, the Netherlands
• 2017: Advance course in immunology, Erasmus University Medical Center, Rotterdam, the Netherlands
• 2017: Dutch Annual Virology Symposium
• 2018: Dutch Annual Virology Symposium
• 2019: Research integrity course, Erasmus University Medical Center, Rotterdam, the Netherlands
• 2019: Grant proposal writing, Erasmus University Medical Center, Rotterdam, the Netherlands
• 2024: The 12th Jakarta International Chest and Critical Care Internal Medicine (JICCIM) Symposium, Jakarta, Indonesia
• 2024: Scientific Harmony: Strengthening International Relations Through Medical Journal Collaboration in ASEAN Countries, Jakarta, Indonesia

Publications

• Anfasa F, Nainggolan L, Urfa EL, van den Ham HJ, Pranata AJ, Arodes ES, et al. Plasma leakage is associated with microbial translocation, production of inflammatory mediators and endothelial cell activation in a cohort of dengue patients. (submitted)
• Nainggolan L, Anfasa F, Mansjoer A, Dewi BE Endocan as a marker of plasma leakage in dengue patients: a diagnostic study. BMC Infect Dis (under revision)
• Oktaria S, Anfasa F, Menaldi SL, Bramono K, Nijsten TEC, Thio HB. Serum Interleukin 6 Level and Nutrition Status as Potential Predictors of Clinical Leprosy Development Among Household Contacts in Endemic Areas. Open Forum Infect Dis. 2022;9(3):ofac010
• Longmore DK, Miller JE, Bekkering S, Saner C, Mifsud E, Zhu Y, Saffery R, Nichol A, Colditz G, Short KR, Burgner DP; International BMICOVID consortium. Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19: An International, Multicenter Retrospective Meta-analysis. Diabetes Care. 2021;44:1281-90.
• Douglas KO, Dutta SK, Martina B, Anfasa F, Samuels TA, Gittens-St. Hilaire M. Dengue and severe dengue Epidemiology of dengue fever in Barbados, 2008-2016. Trop Med Infect Dis. 2020;5:68
• Anfasa F, Lim SM, Wever R, Fekken S, Osterhaus ADME, Martina BE. Characterization of antibody response in patients with acute and chronic chikungunya virus disease. J Clin Virol. 2019;117:68-72.
• Anfasa F, Goeijenbier M*, Widagdo W*, Siegers JY, Mumtaz N, Okba N, van Riel D, Rockx B, Koopmans MPG, Meijers JCM, Martina BEE. Zika Virus Infection Induces Elevation of Tissue Factor Production and Apoptosis on Human Umbilical Vein Endothelial Cells. Front Microbiol. 2019;10:817
• Anfasa F*, Siegers JY*, van der Kroeg M, Mumtaz N, Raj VS, de Vrij FMS, WidagdoW, GabrielG, SalinasS, SimoninY, Reusken C, Kushner SA, Koopmans MPG, HaagmansB, Martina BEE, van Riel D. Phenotypic differences between Asian and African lineage zika viruses in human neural progenitor cells. mSphere. 2017;2:e00292-17
• Anfasa F*, Provacia L*, GeurtsvanKessel C, Wever R, Gerstenbluth I, Osterhaus ADME, Martina BEE. Hyperferritinemia is a potential marker of chronic chikungunya: A retrospective study on the Island of Curaçao during the 2014-2015 outbreak. J Clin Virol. 2017;86:31-8
• Roosenhoff R, Anfasa F, Martina B. The pathogenesis of chronic chikungunya: evolving concepts. Fut Virol. 2016;11:61-77
• Anfasa F, Nainggolan L, Martina BEE. Dengue virus infection in humans: epidemiology, biology, pathogenesis and clinical aspects. In: Singh SK, editor. Human Emerging and Re-Emerging Infections: Viral & Parasitic Infections, Volume I. New Jersey: John Wiley& Sons; 2015 p.125-44.

Presentations

• 2013-2019: Lab meetings, Departement of Viroscience, Erasmus MC
• 2016: 1st ICE on IMERI, Jakarta, Indonesia
• 2017: 21st Molecular Medicine Day
• 2017: Dutch Arboviral Network Meeting
• 2017: 2nd International Meeting on Arboviruses and Their Vectors, Glasgow, Scotland
• 2017: 10th European Congress of Tropical Medicine and International Health, Antwerp, Belgium 
• 2018: 22nd Molecular Medicine Day
• 2019: 23rd Molecular Medicine Day